Announcement of Meeting of the Secretary's Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2030, 15361-15362 [2017-06033]

Download as PDF Federal Register / Vol. 82, No. 58 / Tuesday, March 28, 2017 / Notices 15361 TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1 Number of respondents Portion of study Number of responses per respondent Total annual responses Screening for pretest .................................... Pretest ........................................................... Screening for main data collection ............... Main data collection ...................................... 762 100 19,082 2,500 1 1 1 1 762 100 19,082 2,500 Total ....................................................... ........................ ........................ ........................ sradovich on DSK3GMQ082PROD with NOTICES 1 There Average burden per response .033 (2 .25 (15 .033 (2 .25 (15 minutes) minutes) minutes) minutes) Total hours ................... ................... ................... ................... 25 25 630 625 ............................................... 1,305 are no capital costs or operating and maintenance costs associated with this collection of information. FDA’s burden estimate is based on prior experience with research that is similar to this proposed study. Screening potential participants for the 2 pretests will occur with 762 respondents (487 adults and 275 adolescents) identified and recruited through the Internet panel. This brief screening will take an average of 2 minutes (0.033 hours) per respondent. Each of the 2 pretests will consist of 50 respondents (34 adults and 16 adolescents) conducted during a single session and take an average of 15 minutes (0.25 hours) per respondent. Screening potential participants for the main data collection will occur with 19,082 respondents (11,925 adults and 7,157 adolescents) identified and recruited through the same Internet panel as used for the pretests. This brief screening will take an average of 2 minutes (0.033 hours) per respondent. Recent national estimates of the numbers of adolescent current cigarette smokers, adolescents who are susceptible to initiation of cigarette smoking, young adult current cigarette smokers, and older adult current cigarette smokers informed the estimates of 13.9 percent qualification rate for adults and 11.6 percent qualification rate for adolescents. Applying these estimates and other assumptions from previous experience conducting similar studies to the number of adolescents and adults to be screened results in the desired sample size for the main data collection of 2,500 participants, of which 1,667 will be adults and 833 will be adolescents. The main data collection will occur with those 2,500 respondents during a single session. The main data collection will take an average of 15 minutes (0.25 hours) per respondent. The total estimated burden is 1,305 hours (25 hours + 25 hours + 630 hours + 625 hours). VerDate Sep<11>2014 17:14 Mar 27, 2017 Jkt 241001 Dated: March 22, 2017. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2017–06078 Filed 3–27–17; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Announcement of Meeting of the Secretary’s Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2030 Office of Disease Prevention and Health Promotion, Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. AGENCY: ACTION: Notice. The U.S. Department of Health and Human Services (HHS) announces the next federal advisory committee meeting regarding the development of national health promotion and disease prevention objectives for 2030. This meeting will be held online via webinar and is open to the public. The Committee will discuss the nation’s health promotion and disease prevention objectives and will provide recommendations to improve health status and reduce health risks for the nation by the year 2030. The Committee will advise the Secretary on the Healthy People 2030 mission, vision, framework, and organizational structure. The Committee will provide advice regarding criteria for identifying a more focused set of measurable, nationally representative objectives. The Committee’s advice must assist the Secretary in reducing the number of objectives while ensuring that the selection criteria identifies the most critical public health issues that are high-impact priorities supported by current national data. SUMMARY: The Committee will meet on April 27, 2017, from 12:00 p.m. to 2:00 p.m. Eastern Time (ET). DATES: PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 The meeting will be held online via webinar. To register to attend the meeting, please visit the Healthy People Web site at http:// www.healthypeople.gov. FOR FURTHER INFORMATION CONTACT: Emmeline Ochiai, Designated Federal Officer, Secretary’s Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2030, U.S. Department of Health and Human Services, Office of the Assistant Secretary for Health, Office of Disease Prevention and Health Promotion, 1101 Wootton Parkway, Room LL–100, Rockville, MD 20852, (240) 453–8280 (telephone), (240) 453–8281 (fax). Additional information is available on the Healthy People Web site at http:// www.healthypeople.gov. SUPPLEMENTARY INFORMATION: The names and biographies of the Committee members are available at https://www.healthypeople.gov/2020/ about/history-development/healthypeople-2030-advisory-committee. Purpose of Meeting: Through the Healthy People initiative, HHS leverages scientific insights and lessons from the past decade, along with new knowledge of current data, trends, and innovations, to develop the next iteration of national health promotion and disease prevention objectives. Healthy People provides science-based, 10-year national objectives for promoting health and preventing disease. Since 1979, Healthy People has set and monitored national health objectives that meet a broad range of health needs, encourage collaboration across sectors, guide individuals toward making informed health decisions, and measure the impact of our prevention and health promotion activities. Healthy People 2030 health objectives will reflect assessments of major risks to health and wellness, changing public health priorities, and emerging technologies related to our nation’s health preparedness and prevention. Public Participation at Meeting: Members of the public are invited to ADDRESSES: E:\FR\FM\28MRN1.SGM 28MRN1 15362 Federal Register / Vol. 82, No. 58 / Tuesday, March 28, 2017 / Notices join the online Committee meeting. There will be no opportunity for oral public comments during this online Committee meeting. However, written comments are welcome throughout the entire development process of the national health promotion and disease prevention objectives for 2030 and may be emailed to HP2030@hhs.gov. To join the Committee meeting, individuals must pre-register at the Healthy People Web site at http:// www.healthypeople.gov. Participation in the meeting is limited. Registrations will be accepted until maximum webinar capacity is reached and must be completed by 9:00 a.m. ET on April 26, 2017. A waiting list will be maintained should registrations exceed capacity, and those individuals will be contacted as additional space for the meeting becomes available. Registration questions may be directed to: Jim Nakayama at events@ nakamotogroup.com, or (240) 672–4011. Date: March 29, 2017. Time: 1:00 p.m. to 3:30 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W104, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Eun Ah Cho, Ph.D., Chief, Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W104, Bethesda, MD 20892–9750, 240–276–6342, choe@mail.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Authority: 42 U.S.C. 217a. The Secretary’s Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2030 is governed by provisions of the Federal Advisory Committee Act (FACA), Public Law 92–463, as amended (5 U.S.C., App.) which sets forth standards for the formation and use of federal advisory committees. Dated: March 22, 2017. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. Dated: March 10, 2017. Don Wright, Deputy Assistant Secretary for Health (Disease Prevention and Health Promotion). DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2017–06033 Filed 3–27–17; 8:45 am] National Library of Medicine; Notice of Meeting BILLING CODE 4150–32–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health sradovich on DSK3GMQ082PROD with NOTICES National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel; NCI Provocative Question #10. VerDate Sep<11>2014 17:14 Mar 27, 2017 Jkt 241001 [FR Doc. 2017–06039 Filed 3–27–17; 8:45 am] BILLING CODE 4140–01–P 20894, 301–435–5985, dlipman@ mail.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. (Catalogue of Federal Domestic Assistance Program No. 93.879, Medical Library Assistance, National Institutes of Health, HHS). Dated: March 22, 2017. Michelle Trout, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2017–06045 Filed 3–27–17; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meeting National Institutes of Health Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App), notice is hereby given of a meeting of the PubMed Central National Advisory Committee. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Name of Committee: PubMed Central National Advisory Committee. Date: June 21, 2017. Time: 2:00 p.m. to 4:00 p.m. Agenda: Review and Analysis of Systems. Place: National Library of Medicine, Building 38, 2nd Floor, The Lindberg Room, 8600 Rockville Pike, Building 38, Conference Room B, Bethesda, MD 20892 (Teleconference). Contact Person: David J. Lipman, MD, Director, National Center for Biotechnology Information, National Library of Medicine, Building 38, Room 8N807, Bethesda, MD PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2); notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The purpose of this meeting is to evaluate requests for preclinical development resources for potential new therapeutics for the treatment of cancer. The outcome of the evaluation will provide information to internal NCI committees that will decide whether NCI should support requests and make available contract resources for development of the potential therapeutic to improve the treatment of various forms of cancer. The research proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the proposed research projects, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. E:\FR\FM\28MRN1.SGM 28MRN1

Agencies

[Federal Register Volume 82, Number 58 (Tuesday, March 28, 2017)]
[Notices]
[Pages 15361-15362]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-06033]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Announcement of Meeting of the Secretary's Advisory Committee on 
National Health Promotion and Disease Prevention Objectives for 2030

AGENCY: Office of Disease Prevention and Health Promotion, Office of 
the Assistant Secretary for Health, Office of the Secretary, Department 
of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The U.S. Department of Health and Human Services (HHS) 
announces the next federal advisory committee meeting regarding the 
development of national health promotion and disease prevention 
objectives for 2030. This meeting will be held online via webinar and 
is open to the public. The Committee will discuss the nation's health 
promotion and disease prevention objectives and will provide 
recommendations to improve health status and reduce health risks for 
the nation by the year 2030. The Committee will advise the Secretary on 
the Healthy People 2030 mission, vision, framework, and organizational 
structure. The Committee will provide advice regarding criteria for 
identifying a more focused set of measurable, nationally representative 
objectives. The Committee's advice must assist the Secretary in 
reducing the number of objectives while ensuring that the selection 
criteria identifies the most critical public health issues that are 
high-impact priorities supported by current national data.

DATES: The Committee will meet on April 27, 2017, from 12:00 p.m. to 
2:00 p.m. Eastern Time (ET).

ADDRESSES: The meeting will be held online via webinar. To register to 
attend the meeting, please visit the Healthy People Web site at http://www.healthypeople.gov.

FOR FURTHER INFORMATION CONTACT: Emmeline Ochiai, Designated Federal 
Officer, Secretary's Advisory Committee on National Health Promotion 
and Disease Prevention Objectives for 2030, U.S. Department of Health 
and Human Services, Office of the Assistant Secretary for Health, 
Office of Disease Prevention and Health Promotion, 1101 Wootton 
Parkway, Room LL-100, Rockville, MD 20852, (240) 453-8280 (telephone), 
(240) 453-8281 (fax). Additional information is available on the 
Healthy People Web site at http://www.healthypeople.gov.

SUPPLEMENTARY INFORMATION: The names and biographies of the Committee 
members are available at https://www.healthypeople.gov/2020/about/history-development/healthy-people-2030-advisory-committee.
    Purpose of Meeting: Through the Healthy People initiative, HHS 
leverages scientific insights and lessons from the past decade, along 
with new knowledge of current data, trends, and innovations, to develop 
the next iteration of national health promotion and disease prevention 
objectives. Healthy People provides science-based, 10-year national 
objectives for promoting health and preventing disease. Since 1979, 
Healthy People has set and monitored national health objectives that 
meet a broad range of health needs, encourage collaboration across 
sectors, guide individuals toward making informed health decisions, and 
measure the impact of our prevention and health promotion activities. 
Healthy People 2030 health objectives will reflect assessments of major 
risks to health and wellness, changing public health priorities, and 
emerging technologies related to our nation's health preparedness and 
prevention.
    Public Participation at Meeting: Members of the public are invited 
to

[[Page 15362]]

join the online Committee meeting. There will be no opportunity for 
oral public comments during this online Committee meeting. However, 
written comments are welcome throughout the entire development process 
of the national health promotion and disease prevention objectives for 
2030 and may be emailed to HP2030@hhs.gov.
    To join the Committee meeting, individuals must pre-register at the 
Healthy People Web site at http://www.healthypeople.gov. Participation 
in the meeting is limited. Registrations will be accepted until maximum 
webinar capacity is reached and must be completed by 9:00 a.m. ET on 
April 26, 2017. A waiting list will be maintained should registrations 
exceed capacity, and those individuals will be contacted as additional 
space for the meeting becomes available. Registration questions may be 
directed to: Jim Nakayama at events@nakamotogroup.com, or (240) 672-
4011.

    Authority: 42 U.S.C. 217a. The Secretary's Advisory Committee on 
National Health Promotion and Disease Prevention Objectives for 2030 
is governed by provisions of the Federal Advisory Committee Act 
(FACA), Public Law 92-463, as amended (5 U.S.C., App.) which sets 
forth standards for the formation and use of federal advisory 
committees.

    Dated: March 10, 2017.
Don Wright,
Deputy Assistant Secretary for Health (Disease Prevention and Health 
Promotion).
[FR Doc. 2017-06033 Filed 3-27-17; 8:45 am]
BILLING CODE 4150-32-P